Chronic lymphocytic Leukaemia: Current Practice and Future - 12 Feb 2021

Part 1 - Welcome address by Dr Prashant S P, Astra Zeneca
Part 2 - Introduction of guest speaker - Dr. Poonam Patil, Bengaluru
Part 3 - Expert guidance on management of CLL patients with Acalabrutinib - Prof. Peter Hillmen, UK
Part 4 - Q & A - Prof. Peter Hillmen, UK
Part 5 - How do I manage my CLL patients, Current treatment & Challenges in Indian context- Dr. Ashish
Part 6 - Case based discussion - Dr. Sharat Damodar, Bengaluru
Part 7 - Vote of thanks by Dr Prashant S P, Astra Zeneca